Highnoon Laboratories Limited (PSX:HINOON)
Pakistan · Delayed Price · Currency is PKR 978.00
+18.54 (1.93%)
At close: May 8, 2026
Highnoon Laboratories Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28,200 | 27,706 | 24,641 | 19,766 | 15,816 | 13,001 | |
Revenue Growth (YoY) | 10.53% | 12.44% | 24.66% | 24.98% | 21.65% | 21.53% |
Cost of Revenue | 12,313 | 12,514 | 12,236 | 10,368 | 7,625 | 6,475 |
Gross Profit | 15,887 | 15,192 | 12,405 | 9,398 | 8,190 | 6,526 |
Selling, General & Admin | 8,417 | 8,304 | 6,865 | 5,720 | 4,649 | 3,985 |
Research & Development | 10.79 | 10.79 | 9.47 | 15.02 | 10.63 | 8.67 |
Other Operating Expenses | 602.24 | 560.18 | 533.91 | -46.41 | 321.04 | 219.11 |
Operating Expenses | 9,030 | 8,875 | 7,408 | 5,688 | 4,981 | 4,213 |
Operating Income | 6,857 | 6,317 | 4,997 | 3,710 | 3,209 | 2,313 |
Interest Expense | -106.07 | -114.01 | -395.03 | -149.21 | -57.07 | -27.44 |
Interest & Investment Income | 58.97 | 58.97 | 151.36 | 99.43 | 233.75 | 132.59 |
Currency Exchange Gain (Loss) | -23.31 | -23.31 | 1.37 | -335.58 | -7.15 | 2.52 |
Other Non Operating Income (Expenses) | -5.2 | 4.82 | 12.94 | 45.33 | 38.79 | -2.42 |
EBT Excluding Unusual Items | 6,781 | 6,244 | 4,768 | 3,370 | 3,418 | 2,418 |
Gain (Loss) on Sale of Investments | 344.77 | 344.77 | 236.95 | -24.44 | 9.25 | 10.59 |
Gain (Loss) on Sale of Assets | 15.53 | 15.53 | 27.9 | 13.82 | 18.17 | 6.75 |
Pretax Income | 7,141 | 6,604 | 5,032 | 3,359 | 3,445 | 2,436 |
Income Tax Expense | 2,920 | 2,476 | 1,644 | 911.61 | 972.46 | 579.32 |
Earnings From Continuing Operations | 4,222 | 4,128 | 3,389 | 2,448 | 2,473 | 1,856 |
Net Income | 4,222 | 4,128 | 3,389 | 2,448 | 2,473 | 1,856 |
Net Income to Common | 4,222 | 4,128 | 3,389 | 2,448 | 2,473 | 1,856 |
Net Income Growth | 19.46% | 21.83% | 38.44% | -1.01% | 33.20% | 25.96% |
Shares Outstanding (Basic) | 53 | 53 | 53 | 53 | 53 | 53 |
Shares Outstanding (Diluted) | 53 | 53 | 53 | 53 | 53 | 53 |
Shares Change (YoY) | 0.01% | - | - | - | - | - |
EPS (Basic) | 79.68 | 77.92 | 63.95 | 46.20 | 46.67 | 35.04 |
EPS (Diluted) | 79.68 | 77.92 | 63.95 | 46.20 | 46.67 | 35.04 |
EPS Growth | 19.45% | 21.83% | 38.44% | -1.01% | 33.20% | 25.96% |
Free Cash Flow | 1,820 | 1,365 | 4,143 | 883.21 | -1,237 | 1,430 |
Free Cash Flow Per Share | 34.34 | 25.76 | 78.20 | 16.67 | -23.34 | 26.99 |
Dividend Per Share | 50.000 | 50.000 | 40.000 | 30.000 | 15.810 | 14.373 |
Dividend Growth | 25.00% | 25.00% | 33.33% | 89.75% | 10.00% | 46.67% |
Gross Margin | 56.34% | 54.83% | 50.34% | 47.55% | 51.79% | 50.20% |
Operating Margin | 24.32% | 22.80% | 20.28% | 18.77% | 20.29% | 17.79% |
Profit Margin | 14.97% | 14.90% | 13.75% | 12.38% | 15.63% | 14.28% |
Free Cash Flow Margin | 6.45% | 4.93% | 16.81% | 4.47% | -7.82% | 11.00% |
EBITDA | 7,198 | 6,657 | 5,252 | 3,908 | 3,392 | 2,480 |
EBITDA Margin | 25.52% | 24.03% | 21.31% | 19.77% | 21.45% | 19.08% |
D&A For EBITDA | 341.4 | 339.35 | 254.82 | 198.44 | 182.75 | 166.87 |
EBIT | 6,857 | 6,317 | 4,997 | 3,710 | 3,209 | 2,313 |
EBIT Margin | 24.32% | 22.80% | 20.28% | 18.77% | 20.29% | 17.79% |
Effective Tax Rate | 40.88% | 37.49% | 32.67% | 27.14% | 28.23% | 23.78% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.